CA
NZ
UK
AU
IND
US
A statement of changes in beneficial ownership was filed on November 9, 2026, disclosing that Steven F. Rocco, a director and portfolio manager at Lord Abbett Credit Opportunities Fund, purchased common shares on November 5, 2026.
CBL & Associates Properties, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting condensed consolidated financial results for the three and nine months ended September 30, 2026.
Brian Valania, Chief Executive Officer, Chief Financial Officer, and director of Mitesco, Inc., filed Amendment No. 1 to Schedule 13D on November 9, 2026, disclosing beneficial ownership of 3,504,412 shares of Mitesco common stock and 12,000 shares of Series X Preferred Stock as of …
Apollo Global Management, Inc. filed a Free Writing Prospectus on November 9, 2026, disclosing the final pricing terms for a $600,000,000 offering of 7.550% Fixed-Rate Resettable Junior Subordinated Notes due 2056.
Brian Valania, CEO and CFO of Mitesco, Inc., filed a Form 4 on November 9, 2026, disclosing multiple acquisitions of common stock and Series X Preferred Stock across transactions dated from July 29, 2024 through November 5, 2026.
Christopher James Stevens, an officer of Rocket Pharmaceuticals, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 16,131 shares of common stock on NASDAQ under Rule 144 of the Securities Act of 1933.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) fact sheet on November 9, 2026, disclosing terms for Market Linked Securities auto-callable with leveraged upside participation and contingent downside, linked to the lowest performing of the S&P 500 Index and the Dow …
Astera Labs, Inc. director Stefan A. Dyckerhoff filed an amended Form 144 notice on November 9, 2026, disclosing a proposed sale of 12,499 shares of Astera Labs common stock with an approximate sale date of November 5, 2026, through broker Stifel Nicolaus & Company …
United Airlines Holdings, Inc. officer Kate Gebo filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 28,283 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ:UAL.
Sarbani Chaudhuri, an officer of Rocket Pharmaceuticals, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 4,872 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ:RCKT.
Please wait processing your request...